Cancer is not a single disease; it is a complex and heterogeneous disease, which leads to the second cause of death worldwide. Although all cancers manifest themselves as an uncontrolled growth of abnormal cells, they are actually distinct neoplastic diseases that possess different genetic and epigenetic alterations, underlying molecular mechanisms, histopathologies and clinical outcomes. Despite significant advances in the understanding of the principal mechanisms leading to various cancer types, less progress has been made toward developing patient-specific treatments. Advanced mathematical and computational models could play a significant role in examining the most effective patient-specific therapies. There is a pressing need to design and develop computational strategies to harness cancer data in an accurate and efficient fashion.
The purpose of the International Symposium on Mathematical and Computational Oncology (ISMCO) is to provide a common interdisciplinary forum for researchers, scientists, engineers and clinical oncologists throughout the world to present and discuss their latest research findings, ideas, developments and applications in mathematical and computational oncology. In particular, ISMCO aspires to enable the forging of stronger relationships among physical sciences, computer science, data science, engineering and oncology with the goal of developing new insights into the pathogenesis and treatment of malignancies.
The symposium will consist of invited and contributed presentations dealing with all aspects of mathematical and computational oncology. In addition, it will include keynote presentations, tutorials, special tracks, panel discussions, and a poster session. A “best paper award” will also be sponsored. The symposium’s proceedings will be published by Springer-Verlag in the Lecture Notes in Computer Science (LNCS) series.. LNCS publications are indexed by SCOPUS.
ISMCO Steering Committee:
ISMCO seeks papers describing contributions to the state of the art and practice in mathematical and computational oncology. Work-in-progress papers, demos, experimental studies, open-source developments, and visionary papers are also welcome. Topics of interest include all aspects of mathematical and computational oncology including, but not limited, to the following areas:
04月29日
2019
05月01日
2019
初稿截稿日期
注册截止日期
留言